SonderMind bought failed Mindstrong's assets, hiring 20 of its ~120 staff

SonderMind runs a telemental health platform matching patients with therapists; Mindstrong had pivoted from digital biomarkers for brain disorders to virtual therapy.

Buying distressed assets and teams would make SonderMind the consolidator of behavioral health and deepen its push into high-acuity mental illness

SonderMind CEO Mark Frank told Axios in August 2022 that he saw the company as a 'natural consolidator' which planned to build specialized psychiatric programs and offer more data-driven care by buying up other companies. Mindstrong, co-founded and once helmed by former NIMH director Tom Insel, had raised $160 million on a digital-biomarker pitch before pivoting into crowded telemental health.

Mindstrong halted services and closed its Silicon Valley headquarters in March 2023. SonderMind moved for the assets, hiring about 20 of Mindstrong's employees; the remaining 100 lost their jobs, including CEO Michelle Wagner, who told Modern Healthcare this was 'sort of the final chapter for the Mindstrong care business.'

Asset deal completed in March 2023: about 20 Mindstrong staff joined SonderMind; the rest of the company, including its CEO, was let go.

Mindstrong burned $160 million chasing digital biomarkers, pivoted into generic teletherapy, and ran out of road in a crowded sector.

SonderMind had declared itself a 'natural consolidator' and wanted psychiatric programs and data-driven care it did not have to build.

Distressed assets came cheap: about 20 hires plus care-program know-how, against the $160 million investors put into Mindstrong.

SonderMind had long aimed to deepen its efforts in high-acuity mental illness, and Mindstrong's care programs pointed that way.

In crowded sectors the consolidator wins by waiting: let overfunded rivals die, then pick up their teams and programs for a fraction of the capital sunk into them.

As of the March 23, 2023 report, about 20 former Mindstrong employees had joined SonderMind and the rest of the roughly 120-person company, including CEO Michelle Wagner, were out. Axios framed the deal as potentially a boon for SonderMind's push into high-acuity mental illness; Wagner called it the final chapter for the Mindstrong care business.